Drug General Information
Drug ID
D08JMI
Former ID
DCL001139
Drug Name
ALN-VSP
Drug Type
RNAi therapeutics
Indication Liver cancer [ICD9: 140-229, 155, 203.0; ICD10:C22] Phase 1 [550232]
Company
Alnylam Pharmaceuticals
Target and Pathway
Target(s) mRNA of kinesin spindle protein Target Info [550232]
Reactome MHC class II antigen presentation
Kinesins
WikiPathways MHC class II antigen presentation
Kinesins
References
Ref 550232Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).
Ref 550232Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.